Rampil 1,25 mg/ 2,5 mg/ 5 mg/ 10 mg Hard gelatin capsules
PDF Leaflet Revision Date: 04 January 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Mild to moderate hypertension, cardiac failure post-myocardial infarction, diabetic nephropathy.
Dosage (summary)
Initial: 2.5 mg once daily, titrate to 10 mg as needed.
Special Populations
- Renal impairment
- Elderly
- Paediatric population
Pregnancy & Breastfeeding
Contraindicated in pregnancy; not recommended during breastfeeding.
Key Drug Interactions
- Potassium-sparing diuretics
- Lithium
- NSAIDs
- Fluoroquinolones
Contraindications
- Hypersensitivity to ramipril
- History of angioedema
- Severe renal impairment
- Bilateral renal artery stenosis
Common side effects
- Cough
- Hypotension
- Hyperkalaemia
- Angioedema
Counselling Points
- Take at the same time daily
- Monitor blood pressure regularly
- Report any signs of angioedema immediately
Serious warnings
- Risk of angioedema
- Monitor renal function
- Risk of hypotension in volume-depleted patients
Important Disclaimer
The Rampil 1,25 mg/ 2,5 mg/ 5 mg/ 10 mg Hard gelatin capsules professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
